M3B Fundamental Analysis - PYRAMID AG

Name: PYRAMID AG (M3B) Stock
Brand: PYRAMID AG
Rating: 2 (3 reviews)

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to M3B. M3B was compared to 32 industry peers in the Technology Hardware, Storage & Peripherals industry. M3B has a bad profitability rating. Also its financial health evaluation is rather negative. M3B is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

M3B had negative earnings in the past year.

The reported net income has been mixed in the past 5 years: M3B reported negative net income in multiple years.

M3B had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -0.29%, M3B is not doing good in the industry: 61.29% of the companies in the same industry are doing better.

The Return On Equity of M3B (-0.48%) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-0.29%
ROE	-0.48%
ROIC	N/A

ROA(3y)2.26%

ROA(5y)-2.19%

ROE(3y)3.1%

ROE(5y)-2.17%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

M3B has a worse Gross Margin (-434.35%) than 87.10% of its industry peers.

M3B's Gross Margin has declined in the last couple of years.

M3B does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	-434.35%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y-13.41%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

M3B has more shares outstanding than it did 1 year ago.

M3B has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, M3B has a worse debt to assets ratio.

2.2 Solvency

M3B has an Altman-Z score of 0.40. This is a bad value and indicates that M3B is not financially healthy and even has some risk of bankruptcy.

M3B's Altman-Z score of 0.40 is on the low side compared to the rest of the industry. M3B is outperformed by 67.74% of its industry peers.

A Debt/Equity ratio of 0.28 indicates that M3B is not too dependend on debt financing.

With a decent Debt to Equity ratio value of 0.28, M3B is doing good in the industry, outperforming 70.97% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.28
Debt/FCF	N/A
Altman-Z	0.4

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

M3B has a Current Ratio of 2.94. This indicates that M3B is financially healthy and has no problem in meeting its short term obligations.

M3B has a better Current ratio (2.94) than 87.10% of its industry peers.

M3B has a Quick Ratio of 1.08. This is a normal value and indicates that M3B is financially healthy and should not expect problems in meeting its short term obligations.

With a decent Quick ratio value of 1.08, M3B is doing good in the industry, outperforming 64.52% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.94
Quick Ratio	1.08

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

M3B shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -150.00%.

The Revenue for M3B has decreased by -115.30% in the past year. This is quite bad

The Revenue has been growing by 143.51% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)-150%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-450%

Revenue 1Y (TTM)-115.3%

Revenue growth 3Y441.32%

Revenue growth 5Y143.51%

Sales Q2Q%-19.28%

3.2 Future

The Earnings Per Share is expected to grow by 36.99% on average over the next years. This is a very strong growth

Based on estimates for the next years, M3B will show a quite strong growth in Revenue. The Revenue will grow by 14.62% on average per year.

EPS Next Y40%

EPS Next 2Y78.89%

EPS Next 3Y68.69%

EPS Next 5Y36.99%

Revenue Next Year10.57%

Revenue Next 2Y17.03%

Revenue Next 3Y17.22%

Revenue Next 5Y14.62%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

M3B reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year M3B is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as M3B's earnings are expected to grow with 68.69% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y78.89%

EPS Next 3Y68.69%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

M3B does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PYRAMID AG

FRA:M3B (11/20/2025, 7:00:00 PM)

1.0426

-0.1 (-8.54%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupTechnology Hardware & Equipment

GICS IndustryTechnology Hardware, Storage & Peripherals

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners2.11%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap24.05M

Revenue(TTM)-5.99M

Net Income(TTM)-211.00K

AnalystsN/A

Price Target1.68 (61.14%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	0.55
P/tB	1.85
EV/EBITDA	N/A

EPS(TTM)-0.02

EYN/A

EPS(NY)-0.02

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS-0.26

BVpS1.89

TBVpS0.56

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.29%
ROE	-0.48%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	-434.35%
FCFM	N/A

ROA(3y)2.26%

ROA(5y)-2.19%

ROE(3y)3.1%

ROE(5y)-2.17%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y-13.41%

F-ScoreN/A

Asset Turnover-0.08

Health

		Industry Rank	Sector Rank
Debt/Equity	0.28
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.94
Quick Ratio	1.08
Altman-Z	0.4

F-ScoreN/A

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-150%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-450%

EPS Next Y40%

EPS Next 2Y78.89%

EPS Next 3Y68.69%

EPS Next 5Y36.99%

Revenue 1Y (TTM)-115.3%

Revenue growth 3Y441.32%

Revenue growth 5Y143.51%

Sales Q2Q%-19.28%

Revenue Next Year10.57%

Revenue Next 2Y17.03%

Revenue Next 3Y17.22%

Revenue Next 5Y14.62%

EBIT growth 1Y-350.05%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year458.82%

EBIT Next 3Y94.46%

EBIT Next 5Y54.43%

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

PYRAMID AG / M3B.DE FAQ

Can you provide the ChartMill fundamental rating for PYRAMID AG?

ChartMill assigns a fundamental rating of 2 / 10 to M3B.DE.

What is the valuation status of PYRAMID AG (M3B.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to PYRAMID AG (M3B.DE). This can be considered as Overvalued.

What is the profitability of M3B stock?

PYRAMID AG (M3B.DE) has a profitability rating of 1 / 10.

How financially healthy is PYRAMID AG?

The financial health rating of PYRAMID AG (M3B.DE) is 3 / 10.

Can you provide the expected EPS growth for M3B stock?

The Earnings per Share (EPS) of PYRAMID AG (M3B.DE) is expected to grow by 40% in the next year.

PYRAMID AG (M3B.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

PYRAMID AG / M3B.DE FAQ

Can you provide the ChartMill fundamental rating for PYRAMID AG?

What is the valuation status of PYRAMID AG (M3B.DE) stock?

What is the profitability of M3B stock?

How financially healthy is PYRAMID AG?

Can you provide the expected EPS growth for M3B stock?